Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Role of Experience, Conscious Awareness, and Plasticity in Psilocybin's Behavioral Effects - Follow-Up Study (The RECAP 2 Study)

Next Previous
X
Search
Trial Profile

Role of Experience, Conscious Awareness, and Plasticity in Psilocybin's Behavioral Effects - Follow-Up Study (The RECAP 2 Study)

Status: Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 24 Jan 2025

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Psilocybin (Primary) ; Midazolam
  • Indications Post-traumatic stress disorders
  • Focus Therapeutic Use
  • Acronyms The RECAP 2 Study

    • Most Recent Events

    • 21 Jan 2025 According to a Filament Health media release, the company to ship its drug PEX010, to the University of Wisconsin Madison (UW Madison) for this trial. This study is United States Food and Drug Administration (FDA) authorized. The trial is expected to begin dosing in Q1 2025.
    • 27 Dec 2024 Planned End Date changed from 1 Oct 2027 to 1 Nov 2027.
    • 27 Dec 2024 Planned primary completion date changed from 1 Oct 2027 to 1 Nov 2027.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top